alexa
Reach Us +1-947-333-4405
HPV Vaccination In ARV-treated HIV-infected Adolescents And Young Adults Induces Strong HPV-specific Cell-mediated Immune Responses | 9917
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Vaccines & Vaccination

Veronica Rainone, Daria Trabattoni, Francesca Penagini, Francesca Dinello, Gian Vincenzo Zuccotti, Vania Giacomet, Alessandra Vigano and Mario Clerici
Accepted Abstracts: J Vaccines Vaccin
DOI: 10.4172/2157-7560.S1.018
Abstract
Background: Human Papilloma Virus (HPV)-associated ano-genital infections represent the most common sexually transmitted disease in the general population. The incidence of HPV-associated cancers has been increasing in HIV-infected patients. HPV vaccination may be an important approach to reduce the risk of HPV-associated cancers in HIV-infected patients and a combined strategy of screening and HPV vaccination may guarantee a more adequate prevention of HPV-associated lesions. Immunogenicity of HPV vaccines in HIV-infected patients is still not adequately evaluated. We analysed safety, immunogenicity and efficacy of a quadrivalent HPV vaccine in HIV-infected patients without baseline molecular evidence of vaccine-type HPV infection focusing on HPV-specific cell mediated immunity (CMI). Methods: 31 ARV-treated HIV-infected adolescents (age range 28-14 years, mostly with undetectable viremia and effective CD4 recovery) and 25 sex- and age-matched HIV-seronegative healthy controls were enrolled in the study. Quadrivalent HPV- 16/18/6/11 VLP vaccine (Gardasil?) was administered at baseline, 2 months and 6 months. Safety was evaluated in terms of rate and severity of vaccine-related adverse events. Immune activation (CD4/CD25/HLADRII, CD8/CD25/HLADRII), naїve and memory T-cell patterns and HPV-specific immune responses (CD4/IFN-γ/IL-2, CD8/IFN-γ/TNF-γ, CD8/Perforin/GranzymeB) were evaluated at baseline and after vaccine administrations. Results: Results obtained after the first immunization in HIV-infected individuals show: 1) no changes in CD4 counts, percentage of CD4 cells and HIV viral load; 2) a significant increase in naїve CD8 T-cells, activated CD8 T-cells and in central memory CD4 and CD8 T-cells; 3) a significant reduction in terminally differentiated CD8 T-cells; and 4) a significant augmentation of unstimulated and HPV-specific IL2+/CD4+, IFN-γ+/CD4+, IFN-γ+/CD8+ and TNF-α+/CD8+ T-cells. No differences were observed in Perforin- or Granzyme B-secreting CD8 T-cells. Similar results were obtained in healthy controls. Conclusions: Quadrivalent HPV-16/18/6/11 VLP vaccine induces strong HPV-specific cell-mediated immune responses in ARV-treated HIV-infected individuals that are comparable to those observed in HIV-seronegative controls. HPV-specific CMI is likely an important component of the protective effect of this vaccine, data herein indicating that this component is not impaired in ARV-treated HIV infected individuals.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version